The Interventional Suite Of The Future
This article was originally published in Start Up
Executive Summary
The cardiac interventional suite has historically welcomed high-tech, cutting-edge tools. But with hospitals scrutinizing expenditures more closely than ever before, such tools must now prove themselves. Hospitals are now placing a premium on technologies that can improve safety, efficiency, and flexibility while streamlining workflow. A handful of companies are now offering products designed to meet these needs, and providers are starting to take notice.
You may also be interested in...
Siemens, MRI Interventions Team Up On MRI-Guided Catheter System To Treat Arrhythmias
The two firms are building on a 2009 agreement to offer an MRI-guided alternative for cardiac catheter ablation procedures.
Hybrid ORs Offer New Approach to Cardiac Disease
In the near future, patients who are brought into the hospital in need of a coronary bypass procedure could be wheeled into a hybrid operating room that holds both the operating room and the cardiac catheterization lab. This combination will allow physicians to treat many high risk heart patients in a less invasive manner.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.